BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17076976)

  • 21. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
    Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
    Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep quality in asthma: results of a large prospective clinical trial.
    Mastronarde JG; Wise RA; Shade DM; Olopade CO; Scharf SM;
    J Asthma; 2008 Apr; 45(3):183-9. PubMed ID: 18415823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asthma in Italian conscripts: a four year study.
    Vizzaccaro A; Cirillo I; Tosca MA; Milanese M; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):125-9. PubMed ID: 12793115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria.
    Korn S; Both J; Jung M; Hübner M; Taube C; Buhl R
    Ann Allergy Asthma Immunol; 2011 Dec; 107(6):474-9. PubMed ID: 22123375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical appraisal of antileukotriene use in asthma management.
    Polosa R
    Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prognosis of asthma is good--a 12-year follow-up study. Influence of treatment.
    Porpodis K; Papakosta D; Manika K; Kontakiotis T; Gaga M; Sichletidis L; Gioulekas D
    J Asthma; 2009 Aug; 46(6):625-31. PubMed ID: 19657907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up.
    Cottin V; Khouatra C; Dubost R; Glérant JC; Cordier JF
    Allergy; 2009 Apr; 64(4):589-95. PubMed ID: 19154547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma in smokers: challenges and opportunities.
    Thomson NC; Chaudhuri R
    Curr Opin Pulm Med; 2009 Jan; 15(1):39-45. PubMed ID: 19077704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scheduled asthma management in general practice generally improve asthma control in those who attend.
    Backer V; Bornemann M; Knudsen D; Ommen H
    Respir Med; 2012 May; 106(5):635-41. PubMed ID: 22349066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The quality of asthma treatment in Denmark. How far are we--and how far are our patients?].
    Ulrik CS; Lange P; Plaschke PP; Backer V; Søes-Petersen U; Harving H
    Ugeskr Laeger; 2008 Jan; 170(4):230-4. PubMed ID: 18282453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the level of asthma control among adult patients in two tertiary care centers in Nigeria.
    Desalu OO; Fawibe AE; Salami AK
    J Asthma; 2012 Sep; 49(7):765-72. PubMed ID: 22873357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS), 2001.
    Holt S; Kljakovic M; Reid J;
    N Z Med J; 2003 May; 116(1174):U436. PubMed ID: 12766782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beliefs about medicines predict refill adherence to inhaled corticosteroids.
    Menckeberg TT; Bouvy ML; Bracke M; Kaptein AA; Leufkens HG; Raaijmakers JA; Horne R
    J Psychosom Res; 2008 Jan; 64(1):47-54. PubMed ID: 18157999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence rate to inhaled corticosteroids and their impact on asthma control.
    Lasmar L; Camargos P; Champs NS; Fonseca MT; Fontes MJ; Ibiapina C; Alvim C; Moura JA
    Allergy; 2009 May; 64(5):784-9. PubMed ID: 19183166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations.
    Dusser D; Montani D; Chanez P; de Blic J; Delacourt C; Deschildre A; Devillier P; Didier A; Leroyer C; Marguet C; Martinat Y; Piquet J; Raherison C; Serrier P; Tillie-Leblond I; Tonnel AB; Tunon de Lara M; Humbert M
    Allergy; 2007 Jun; 62(6):591-604. PubMed ID: 17508962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.